EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

The EU-Joint Clinical Assessment Guidance Documents Fail to Address the Significance of Systematic Literature Reviews and Deviate from the State of the Art

Beata Smela iD, Mondher Toumi, Samuel Aballéa iD, Steven Simoens iD, Laurent Boyer iD, Bruno Falissard, Renato Bernardini, Stefano Capri iD, Pascal Auquier

Journal of Market Access & Health Policy · 24.06.2026 · 14 (3) · 37

DOI: 10.3390/jmahp14030037 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Market Access & Health Policy, online erschienen am 24.06.2026. Verfasst von Beata Smela und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clever-Access, 30-415 Cracow, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper summarizes an analysis of the Joint Clinical Assessment (JCA) subgroup’s recommendations for systematic literature reviews (SLRs). While the JCA offers clear guidance on study classification, exclusion criteria reporting, and PRISMA diagram use, several of its recommendations diverge from established best practices in evidence-based medicine (EBM). A comparison with recognized guidelines, such as those from Cochrane and EUnetHTA, reveals that the JCA guidance may lack reliability, comprehensiveness, and reproducibility. Aligning JCA recommendations with gold standards in SLR methodology would address these shortcomings and enhance methodological rigor.

Schlagwörter

Stichwörter der Autor:innen

EU-HTAHealth Technology AssessmentJoint Clinical AssessmentPICOmethodologysystematic literature review

Autor:innen und Institutionen

  • Clever-Access, 30-415 Cracow, Poland.
  • Health Services Research and Quality of Life Center, Aix-Marseille University, 13385 Marseille, France.
  • Inovintell, Mathenesserlaan 447B, 3023 GJ Rotterdam, The Netherlands.
  • Department of Pharmaceutical and Pharmacological Sciences, Catholic University of Leuven, 3000 Leuven, Belgium.
  • Centre de Recherche en Epidemiologie et Santé des Populations, CESP, INSERM U1018, Université Paris-Saclay, 94800 Villejuif, France.
  • Department of Biomedical and Biotechnological Sciences, University of Catania, 95124 Catania, Italy.

ORCID-Profile: Beata Smela, Samuel Aballéa, Steven Simoens, Laurent Boyer, Stefano Capri

Zitieren

APA

Smela, B., Toumi, M., Aballéa, S., Simoens, S., Boyer, L., Falissard, B., Bernardini, R., Capri, S., & Auquier, P. (2026). The EU-Joint Clinical Assessment Guidance Documents Fail to Address the Significance of Systematic Literature Reviews and Deviate from the State of the Art. Journal of Market Access & Health Policy, 14(3), 37. https://doi.org/10.3390/jmahp14030037

Vancouver

Smela B, Toumi M, Aballéa S, Simoens S, Boyer L, Falissard B, et al. The EU-Joint Clinical Assessment Guidance Documents Fail to Address the Significance of Systematic Literature Reviews and Deviate from the State of the Art. Journal of Market Access & Health Policy. 2026;14(3):37. doi:10.3390/jmahp14030037

BibTeX
@article{Smela2026,
  author = {Smela, Beata and Toumi, Mondher and Aballéa, Samuel and Simoens, Steven and Boyer, Laurent and Falissard, Bruno and Bernardini, Renato and Capri, Stefano and Auquier, Pascal},
  title = {The EU-Joint Clinical Assessment Guidance Documents Fail to Address the Significance of Systematic Literature Reviews and Deviate from the State of the Art},
  journal = {Journal of Market Access & Health Policy},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {37},
  doi = {10.3390/jmahp14030037}
}
Kostenlos starten →